학술논문
A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy
Document Type
Article
Author
Source
In Blood Advances 25 August 2020 4(16):3886-3893
Subject
Language
ISSN
2473-9529